Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)

Background: Standard treatment for BCG-refractory urothelial cancer is radical cystectomy. Identification of active agents is clearly warranted. Objective: To determine a safe dose of oral everolimus in combination with standard intravesical gemcitabine and to evaluate the efficacy of this combinati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bladder Cancer
Main Authors: Dalbagni, Guido, Benfante, Nicole, Sjoberg, Daniel D., Bochner, Bernard H., Machele Donat, S., Herr, Harry W., Mc Coy, Asia S., Fahrner, Alicia J., Retinger, Caitlyn, Rosenberg, Jonathan E., Bajorin, Dean F.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2017
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5409047/
https://ncbi.nlm.nih.gov/pubmed/28516156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-170095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados